Lifetime Brands, Inc. — Form 10-Q Summary
Business context and reporting period
Lifetime Brands designs, sources and sells branded kitchenware, tableware and home products through retailers, distributors and its own websites. Reported segments are U.S. and International. This unaudited Form 10-Q covers the three and nine months ended September 30, 2023. The business is seasonal, with most sales historically occurring in the third and fourth quarters.
Key financial metrics
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|
| Net sales | $191.7 million | $186.6 million | $483.5 million | $520.6 million |
| Gross margin | $71.0 million; 37.0% | $67.8 million; 36.4% | $180.8 million; 37.4% | $186.1 million; 35.7% |
| Income from operations | $13.6 million; 7.1% | $7.6 million; 4.1% | $16.2 million; 3.4% | $11.5 million; 2.2% |
| Net income (loss) | $4.2 million | $(6.4) million | $(11.1) million | $(9.4) million |
| Diluted EPS | $0.20 | $(0.30) | $(0.52) | $(0.44) |
| Operating cash flow | Not separately provided for the quarter | Not separately provided for the quarter | $17.0 million | $(20.1) million |
- Q3 sales increased 2.7%, driven by U.S. sales growth of 3.8%, while International sales declined 10.9%.
- For the nine months, sales declined 7.1%, primarily because of retailer inventory rightsizing, weaker demand and lower international replenishment orders.
- Q3 gross margin improved 60 basis points, primarily from U.S. product mix. Nine-month gross margin improved 170 basis points due to lower inbound freight costs, product mix and lower international product and duty costs.
- Interest expense increased to $5.2 million in Q3 and $16.1 million for the nine months, reflecting higher interest rates despite lower average borrowings.
- Q3 net income benefited from substantially lower Vasconia impairment losses compared with the prior year. Nine-month results included $6.8 million of non-cash impairment charges related to the Vasconia investment.
Balance sheet, debt and liquidity
| Balance sheet item | September 30, 2023 | December 31, 2022 |
|---|
| Cash and cash equivalents | $6.3 million | $23.6 million |
| Accounts receivable | $153.5 million | $141.2 million |
| Inventory | $217.7 million | $222.2 million |
| Total assets | $691.7 million | $725.9 million |
| ABL borrowings | $29.3 million | $10.4 million |
| Term loan, net | $197.1 million, including current portion | $242.9 million |
| Stockholders’ equity | $226.4 million | $240.1 million |
- ABL availability was $167.7 million at September 30, 2023, after borrowings and standby letters of credit.
- Management reported total liquidity of approximately $198.8 million, including cash, ABL availability and available receivables funding.
- In June 2023, the Company repurchased $47.2 million of term-loan principal for $95 per $100 of principal and recognized a $1.5 million gain on early debt retirement.
- The term loan carried an 8.93% interest rate and ABL borrowings carried rates ranging from 6.44% to 8.75% at September 30, 2023.
- The Company was in compliance with its debt covenants. It estimated a $15.0 million 2024 excess-cash-flow payment, recorded as current debt.
- Trailing twelve-month pro forma Adjusted EBITDA, as defined under the debt agreements, was $55.8 million. Capital expenditures were $1.8 million for the nine months.
Material changes versus the prior comparable period
- Q3 operating income increased $6.0 million, helped by the absence of the $5.1 million Wallace remediation expense recorded in Q3 2022, stronger U.S. sales and improved gross margin.
- Nine-month operating income increased $4.7 million despite lower sales, reflecting improved gross margin, lower distribution expenses and the absence of the prior-year Wallace remediation expense.
- Cash from operations improved by $37.0 million year over year, primarily due to timing of accounts payable and accrued expenses and lower inventory.
- Financing cash flow shifted to a $32.4 million use from an $18.4 million source, mainly because of the term-loan repurchase and lower revolving-credit borrowings.
- Vasconia equity losses were $9.7 million for the nine months, including $6.8 million of impairment, compared with $7.4 million in the prior-year period.
- Accounts receivable allowances increased to $16.8 million from $14.6 million at year-end, partly reflecting customer credit deterioration, including Bed Bath & Beyond Inc.
Outlook, risks, contingencies and unusual items
- Management expects cash, operating cash flow and ABL availability to fund operations for the next twelve months, but noted that adverse changes could require additional debt or equity financing.
- On October 25, 2023, the Company launched syndication for an amendment and extension of its Term Loan B facility from February 2025 to August 2027. Required lender commitments had been received, with closing expected in the fourth quarter of 2023; the filing does not confirm the final closing.
- Inflation, higher interest rates, supply-chain costs, tariffs, retailer inventory practices, weaker consumer demand, foreign exchange, geopolitical conditions and access to credit markets remain key risks.
- The Wallace EPA matter remains material. The Company has reserved $5.6 million for probable and estimable liabilities related to the initial operable unit, but cannot estimate its ultimate share of liability. A consent decree signed in July 2023 remained subject to court approval at the filing date. Financial assurance of $5.6 million may be required within the next twelve months, potentially reducing ABL availability.
- In the CBP tariff-classification matter, potential additional duties were estimated at $0.6 million, with possible penalties of up to $1.2 million for negligence or $2.4 million for gross negligence. The Company considers the loss reasonably possible but not probable.
- Goodwill was not impaired in the September 30 interim test, but the U.S. reporting unit had only 4% excess fair value over carrying value. One trade name will be reclassified to finite-lived status and amortized over 15 years beginning October 1, 2023.
- The Board declared a quarterly dividend of $0.0425 per share payable February 15, 2024. The Company repurchased $2.5 million of stock during the nine months, with $11.1 million remaining under the authorization.
Important facts for investors to verify
- Whether the Term Loan B amendment and extension closed on the expected terms and how it affects maturity, pricing and covenants.
- The ultimate cash cost and required financial assurance for the Wallace EPA remediation matter.
- Vasconia’s operating performance, debt condition and potential for further investment impairments.
- Whether retailer inventory normalization supports sustained U.S. sales growth after the Q3 improvement.
- Customer credit exposure, accounts receivable allowances and any additional effects from customer bankruptcies or financial distress.
- The Company’s ability to maintain liquidity and covenant compliance while paying elevated variable-rate interest and seasonal working-capital needs.
